Habla Espanol
Home Contact Us Site Map
Richmond Personal Injury Lawyers

 

 

PRESCRIPTION DRUG RECALL NEWS
> Chantix (varenicline)
Fri, 16 May 2008 20:12:00 EDT

UPDATE - Prescribing information revised to include safety information regarding serious neuropsychiatric symptoms in the WARNINGS and PRECAUTIONS sections of the label. Additionally, a Medication Guide for patients is available.


> Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic)
Fri, 16 May 2008 13:50:00 EDT

FDA issues an FDA Alert and Information for Healthcare Professional sheet for Mycophenolate Mofetil (MMF) and Mycophenolic Acid (MPA).


> Trasylol (aprotinin injection)
Wed, 14 May 2008 20:52:00 EDT

Bayer Pharmaceuticals notified the FDA of their intent to remove all remaining supplies of Trasylol from hospital pharmacies and warehouses.


> Heparin Sodium Injection
Fri, 09 May 2008 09:50:00 EDT

FDA requests that health professionals and facilities review and examine all drug/device storage areas to ensure that all recalled heparin products have been removed and are no longer available for patient use.


> Cardinal Alcohol-Free Mouthwash
Tue, 06 May 2008 12:00:00 EDT

Product recalled because of the presence of Burkholderia cepacia.


> May 2008 Patient Safety News
Tue, 06 May 2008 08:45:00 EDT

Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.


> Enbrel (etanercept)
Thu, 01 May 2008 14:00:00 EDT

Prescribing information revised to include a BOXED WARNING regarding the risk of infection including tuberculosis.


> Total Body Formula, Total Body Mega Formula
Thu, 01 May 2008 14:00:00 EDT

FDA analysis reveals high chromium levels in addition to selenium.


> Heparin Sodium Injection
Tue, 29 Apr 2008 08:55:00 EDT

Update to healthcare facilities and healthcare professionals about Heparin and Heparin-containing medical products.


> Digitek (digoxin tablets, USP)
Mon, 28 Apr 2008 15:25:00 EDT

Class I recall because tablets may contain twice the approved level of active ingredient.


News Source: FDA MedWatch